NeueHealth (NYSE:NEUE – Get Free Report) is one of 3 public companies in the “Healthcare Plans” industry, but how does it contrast to its competitors? We will compare NeueHealth to related companies based on the strength of its valuation, risk, analyst recommendations, dividends, institutional ownership, profitability and earnings.
Institutional & Insider Ownership
63.9% of NeueHealth shares are held by institutional investors. Comparatively, 75.4% of shares of all “Healthcare Plans” companies are held by institutional investors. 64.3% of NeueHealth shares are held by company insiders. Comparatively, 32.5% of shares of all “Healthcare Plans” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares NeueHealth and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
NeueHealth | -71.23% | N/A | -1.21% |
NeueHealth Competitors | 0.19% | 5.05% | 2.04% |
Earnings and Valuation
Gross Revenue | Net Income | Price/Earnings Ratio | |
NeueHealth | $1.16 billion | -$1.15 billion | -0.04 |
NeueHealth Competitors | $65.48 billion | $1.34 billion | -0.59 |
NeueHealth’s competitors have higher revenue and earnings than NeueHealth. NeueHealth is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Risk & Volatility
NeueHealth has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, NeueHealth’s competitors have a beta of 0.53, meaning that their average stock price is 47% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and target prices for NeueHealth and its competitors, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
NeueHealth | 0 | 1 | 0 | 0 | 2.00 |
NeueHealth Competitors | 3 | 105 | 337 | 18 | 2.80 |
NeueHealth presently has a consensus price target of $8.00, indicating a potential upside of 30.08%. As a group, “Healthcare Plans” companies have a potential upside of 2.68%. Given NeueHealth’s higher probable upside, equities research analysts clearly believe NeueHealth is more favorable than its competitors.
Summary
NeueHealth competitors beat NeueHealth on 9 of the 13 factors compared.
About NeueHealth
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.